SEC 13F Intelligence

Deep Track Capital, LP / APLSUSD

Deep Track Capital, LP’s Apellis Pharmaceuticals Inc Position

Does Deep Track Capital, LP own Apellis Pharmaceuticals Inc (APLSUSD)? Yes — 4.53M shares worth $182M (+2.98% of its 13F portfolio) as of Q1 2026, down from 7.75M shares the prior filed quarter.

Position Value
$182M
Q1 2026
Shares
4.53M
% of Portfolio
+2.98%
Quarters Held
9
currently held

Position History APLSUSD

Reported value by quarter
Q1 ’24: $59MQ1 ’24Q2 ’24: $96MQ3 ’24: $127MQ3 ’24Q4 ’24: $136MQ1 ’25: $109MQ1 ’25Q2 ’25: $121MQ3 ’25: $181MQ3 ’25Q4 ’25: $195MQ1 ’26: $182MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20264.53M$182M+2.98%
Q4 20257.75M$195M+3.47%
Q3 20258.00M$181M+5.05%
Q2 20257.00M$121M+3.89%
Q1 20255.00M$109M+3.54%
Q4 20244.27M$136M+5.09%
Q3 20244.40M$127M+4.03%
Q2 20242.50M$96M+2.86%
Q1 20241.00M$59M+1.68%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deep Track Capital, LP’s full portfolio or all institutional holders of APLSUSD.